title: Effects of luminal shear stress on cerebral arteries and arterioles.
abstract: The effect of luminal shear stress was studied in cerebral arteries and arterioles. Middle cerebral arteries (MCA) and penetrating arterioles (PA) were isolated from male Long-Evans rats, mounted in a tissue bath, and pressurized. After the development of spontaneous tone, inside diameters were 186 +/- 5 microm (n = 28) for MCA and 65 +/- 3 microm (n = 37) for PA. MCA and PA constricted approximately 20% with increasing flow. Flow-induced constriction persisted in MCA and PA after removal of the endothelium. After removal of the endothelium, the luminal application of a polypeptide containing the Arg-Gly-Asp amino acid sequence (inhibitor of integrin attachment) abolished the flow-induced constriction. Similarly, an antibody specific for the beta(3)-chain of the integrin complex significantly inhibited the flow-induced constriction. The shear stress-induced constriction was accompanied by an increase in vascular smooth muscle Ca(2+). For example, a shear stress of 20 dyn/cm(2) constricted MCA 8% (n = 5) and increased Ca(2+) from 209 +/- 17 to 262 +/- 29 nM (n = 5). We conclude that isolated cerebral arteries and arterioles from the rat constrict to increased shear stress. Because the endothelium is not necessary for the response, the shear forces must be transmitted across the endothelium, presumably by the cytoskeletal matrix, to elicit constriction. Integrins containing the beta(3)-chain are involved with the shear stress-induced constrictions.
authors: Department of Anesthesiology, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA. rbryan@bcm.tmc.edu
authors: R M
authors: RM
authors: Bryan
authors: S P
authors: SP
authors: Marrelli
authors: M L
authors: ML
authors: Steenberg
authors: L A
authors: LA
authors: Schildmeyer
authors: T D
authors: TD
authors: Johnson
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D015703:Antigens, CD / Q000276:immunology / Q000378:metabolism; D000970:Antineoplastic Agents / Q000494:pharmacology; D001160:Arterioles / Q000502:physiology; D002118:Calcium / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000502:physiology*; D004730:Endothelium, Vascular / Q000502:physiology; D005456:Fluorescent Dyes; D016257:Fura-2; D066298:In Vitro Techniques; D039661:Integrin beta3; D008297:Male; D020768:Middle Cerebral Artery / Q000502:physiology*; D018482:Muscle, Skeletal / Q000098:blood supply; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D009842:Oligopeptides / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D010980:Platelet Membrane Glycoproteins / Q000037:antagonists & inhibitors / Q000276:immunology / Q000378:metabolism; D051381:Rats; D020318:Rats, Long-Evans; D013314:Stress, Mechanical; D014661:Vasoconstriction / Q000502:physiology*
chemical_list: D000906:Antibodies; D015703:Antigens, CD; D000970:Antineoplastic Agents; D005456:Fluorescent Dyes; D039661:Integrin beta3; D009842:Oligopeptides; D010446:Peptide Fragments; D010980:Platelet Membrane Glycoproteins; C047981:arginyl-glycyl-aspartic acid; D002118:Calcium; D016257:Fura-2